C
Chandra Bhagat Pharma Ltd
BSE:542934
Chandra Bhagat Pharma Ltd
BSE:542934
Price:
37
INR
8.35%
Market Closed
Market Cap:
₹279.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Chandra Bhagat Pharma Ltd
BSE:542934
|
IN |
|
Gunosy Inc
TSE:6047
|
JP |
Balance Sheet
Balance Sheet Decomposition
Chandra Bhagat Pharma Ltd
Chandra Bhagat Pharma Ltd
Balance Sheet Decomposition is not available for
Chandra Bhagat Pharma Ltd
Chandra Bhagat Pharma Ltd
Balance Sheet
Chandra Bhagat Pharma Ltd
Chandra Bhagat Pharma Ltd
Currency: INR
| Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
6
|
6
|
5
|
1
|
24
|
58
|
64
|
50
|
|
| Cash Equivalents |
6
|
6
|
5
|
1
|
24
|
58
|
64
|
50
|
|
| Short-Term Investments |
46
|
11
|
40
|
8
|
4
|
2
|
1
|
1
|
|
| Total Receivables |
231
|
223
|
320
|
277
|
318
|
280
|
212
|
794
|
|
| Accounts Receivables |
197
|
179
|
263
|
140
|
154
|
150
|
82
|
394
|
|
| Other Receivables |
34
|
45
|
57
|
137
|
163
|
130
|
130
|
400
|
|
| Inventory |
268
|
326
|
439
|
439
|
351
|
342
|
291
|
87
|
|
| Other Current Assets |
2
|
5
|
8
|
4
|
3
|
26
|
13
|
47
|
|
| Total Current Assets |
553
|
571
|
813
|
729
|
700
|
707
|
581
|
979
|
|
| PP&E Net |
6
|
5
|
5
|
4
|
4
|
5
|
7
|
25
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
5
|
11
|
14
|
14
|
13
|
18
|
14
|
|
| Total Assets |
559
N/A
|
581
+4%
|
829
+43%
|
747
-10%
|
718
-4%
|
725
+1%
|
606
-16%
|
1 018
+68%
|
|
| Liabilities | |||||||||
| Accounts Payable |
163
|
155
|
297
|
125
|
129
|
27
|
31
|
132
|
|
| Short-Term Debt |
0
|
0
|
163
|
166
|
156
|
144
|
137
|
141
|
|
| Current Portion of Long-Term Debt |
163
|
100
|
34
|
24
|
20
|
13
|
13
|
10
|
|
| Other Current Liabilities |
46
|
31
|
31
|
26
|
24
|
197
|
88
|
428
|
|
| Total Current Liabilities |
372
|
286
|
525
|
341
|
329
|
381
|
269
|
711
|
|
| Long-Term Debt |
42
|
117
|
115
|
109
|
95
|
54
|
39
|
14
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
71
|
92
|
45
|
41
|
36
|
23
|
22
|
3
|
|
| Total Liabilities |
485
N/A
|
496
+2%
|
684
+38%
|
491
-28%
|
459
-6%
|
458
0%
|
331
-28%
|
728
+120%
|
|
| Equity | |||||||||
| Common Stock |
4
|
4
|
7
|
76
|
76
|
76
|
75
|
75
|
|
| Retained Earnings |
70
|
80
|
138
|
181
|
183
|
191
|
199
|
215
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
74
N/A
|
84
+14%
|
145
+71%
|
257
+78%
|
259
+1%
|
267
+3%
|
275
+3%
|
290
+6%
|
|
| Total Liabilities & Equity |
559
N/A
|
581
+4%
|
829
+43%
|
747
-10%
|
718
-4%
|
725
+1%
|
606
-16%
|
1 018
+68%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
|
Switch to:
Switch to:
See Also
Discover More
